Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
Susanne TemmingMartin KocherErich StoelbenLars HagmeyerDe-Hua ChangKonrad FrankKhosro HekmatJuergen WolfWolfgang W BausRobert SemrauChristian BauesS MarnitzPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2017)
CyberKnife® lung SBRT which allows for real-time tumor tracking and risk-adapted fractionation achieves satisfactory local control and low toxicity rates in inoperable early-stage primary lung cancer patients.